DIARY
BioPharm America & French Biotech Tour East Coast 2010
A 4 days program putting together one day of B2B related to the topics "Neurosciences, autoimmunity and inflammation" with the partnering convention BioPharm America
Lyonbiopole invite you to participate from 14 to 17 September 2010 at the Convention BIOPHARM AMERICA, Boston, organized by EBD, preceded by the French Biotech Tower, Philadelphia, organized by UbiFrance.
Thanks to the support and actions of UbiFrance, a program of meetings is offered at a discount price extremely attractive. In addition, you can benefit from the Lyonbiopole international technology partnerships program.
> A 4 days program of business meetings and networking.
These meetings are held in Philadelphia and Boston, 14 to 17 September 2010. They are available to all French biotechnology company (drug discovery / development, diagnostics, CRO / CMO, technology transfer) wishing to develop partnerships atlantic overseas.
- September 14, 2010 in Philadelphia: French Biotech Tour
B2B appointment prevalidated by you and the Ubifrance biotech team in the United States.
The therapeutic areas targeted for this day will be CNS diseases, autoimmune and inflammatory diseases;
Among the 30 companies which have already expressed an interest in the French Biotech Tour include Abbott, Pfizer, Sanofi-Aventis, Merck, Boehringer-Ingelheim, AstraZeneca and Medimmune.
In March 2010, the previous edition of French Biotech Tour had attracted 40 French and American companies such as Novartis, Merck, Sanofi-Aventis and Sanofi-Pasteur.
For returns of companies that have already participated at French Biotech Tour, you can view our short video: www.youtube.com/watch?v=PrUDyUMH040
- 15 to 17 September 2010 in Boston : BioPharm America, an event organized by EBD group (www.ebdgroup.com / bpa).
With events such as Bio-Europe or BioEquity, EBD is a reference. The 2009 BioPharm America had over 430 participating companies and 1550 organized meetings.
> An extremely attractive negotiated prices
The registration fee for four days is 1,000 EUR per person.
By comparison, the "public" rate to participate only for BioPharm America is 1400 EUR.
This rate may be supplemented by financial support from Lyonbiopole within your international technological partnerships program.
> The Experienced UBIFRANCE
UbiFrance accompanies each year over a 100 of French biotech companies in the U.S.
Here is some feedback from U.S. companies that participated in the last French Biotech Tour:
"Competing with IS Ubifrance UK Trade Organizations and various U.S. states for attention of U.S. biotech companies in the major (well funded) rentals. I was happily surprised by the quality of companies at the San Francisco event. That was the dominant factor (location was nice, food was nice, were nice cocktail none of purpose that really matters compared to quality of contacts). "Larry Kauvar, Trellis Bioscience, Inc.
"The French Biotech Tour was annum effective and enjoyable forum to connect a disparate group of companies with symbiotic goals. It was establishing effective connections within a year "as well as France was the local level." - Daniel Dornbusch, Associate Director, business development & strategic operations, Novartis Diagnostics
For a list of participating companies during the last French Biotech Tour : www.ubifrance-events.com/frenchbiotechtour/infectiousdiseases-california/companies.php.
Contact : Ubifrance Isabelle Tanneau, roadstead Advisor - Biotech
isabelle.tanneau @ ubifrance.fr - Tel: +1 415 568 4581
Add me on LinkedIn http://www.linkedin.com/in/isabelletanneau
UBIFRANCE - French Embassy Trade Office, 88 Kearny Street, Suite 700, San Francisco, CA 94108
www.ubifrance.fr | French Biotech Tour
Check out the French Biotech Tour video!
> Do not hesitate: contact us
- Sign up for French Biotech Tour
- You know how to register for your overall UbiFrance
- Continue or start your partnership program with international technology Lyonbiopole
